Gotham Makker - Jun 14, 2021 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: Director
Signature: /s/ Sara Turken, as attorney-in-fact
Stock symbol: RCKT
Transactions as of: Jun 14, 2021
Transactions value $: $44,983
Form type: 4
Date filed: 6/16/2021, 08:13 PM
Next filing: Jun 21, 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCKT	Stock Option (Right to Buy)	Award	$0	+12.2K		$0.00	12.2K	Jun 14, 2021	Common Stock	12.2K	$47.25	Direct	F1
transaction	RCKT	Stock Option (Right to Buy)	Award	$45K	+1.53K		$29.42	1.53K	Jun 14, 2021	Common Stock	1.53K	$47.25	Direct	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022.
F2	This option represents a right to purchase a total of 1,529 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $45,000.